Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Biotech down again in 3Q19

Winners, losers by market cap tier in 3Q19

Meredith Durkin Wolfe, Associate Editor, Data & Analytics
October 4, 2019 7:43 PM UTC

Biotech stocks are continuing a downward trend, with all market cap tiers losing value in 3Q19, leading to a total quarterly loss of $88.8 billion.

Companies valued at $1-$4.9 billion, $5-$9.9 billion and above $10 billion saw median losses of 9%...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Bristol Myers Squibb Co.

Clovis Oncology Inc.

Deciphera Pharmaceuticals Inc.

Galapagos N.V.

Genmab A/S

Gilead Sciences Inc.

Nektar Therapeutics